Consun Pharmaceutical Group Limited (01681) released an update on its share repurchases from 14 October 2025 to 30 October 2025. According to the announcement, a total of 2,650,000 shares were repurchased during this period. These repurchased shares have not yet been cancelled, and the total issued shares remain at 847,973,407 as of 30 October 2025.
On 30 October 2025, the company repurchased 280,000 shares at a highest price of HKD 15.08 and a lowest price of HKD 14.96, for an aggregate price of HKD 4,205,320. The latest resolution, dated 22 May 2025, authorised the repurchase of up to 85,126,334 shares by the company, of which 7,845,000 shares (approximately 9.2157%) have been repurchased to date. The announcement states that the transactions were made in compliance with relevant listing rules and regulatory requirements, and there was no change in the total number of issued shares at the end of the reporting period.